This case report describes a 12-year-old female patient who presented with symptoms of Type A insulin resistance syndrome and polycystic ovary syndrome. She was not obese but had severe high insulin levels. Medical teams identified a new genetic change in the INSR gene that was not present in her parents. This specific change is called a de novo variant. The genetic finding was classified as likely pathogenic according to standard medical guidelines. This discovery expands the known list of gene changes that can cause these conditions in young people. The report also reviews similar cases reported since 2010 to provide more context. Long-term care for this condition requires a team approach involving doctors and nutritionists. Treatment plans must be tailored to the individual patient. This includes medication, medical nutrition therapy, and lifestyle changes. The diagnostic process shows that genetic testing is important for teens with atypical features. It helps explain why some patients do not respond to standard treatments. This report adds to the understanding of how these rare genetic conditions develop.
Genetic test clarifies rare insulin resistance in teen with PCOS
Photo by Mykenzie Johnson / Unsplash
What this means for you:
Genetic testing can clarify rare insulin resistance in teens with PCOS features and guide personalized care plans. More on Polycystic Ovary Syndrome
Systematic review links metabolic dysregulation to impaired oocyte quality and embryonic development potential Metabolic chaos harms egg quality and early embryo growth
Frontiers · May 21, 2026
Systematic bibliometric review maps nutritional strategy research in polycystic ovary syndrome Research reveals top nutrition strategies for PCOS
Frontiers · May 20, 2026
Tai Chi and dietary adjustment for improving health lifestyle in women with PCOS Tai Chi and diet may help manage PCOS symptoms
Frontiers · Apr 30, 2026
Narrative review proposes redox-guided framework for vitamin D, myo-inositol, and melatonin in PCOS Researchers propose new PCOS framework using vitamin D and melatonin
Frontiers · Apr 28, 2026